Last updated: February 14, 2026
Overview
The drug with NDC 21922-0049 is a specialized pharmaceutical product. This analysis focuses on current market presence, competitive landscape, pricing, and future trends.
Product Description
NDC 21922-0049 is a [specify drug name], indicated for [specify approved indications]. It is produced by [manufacturer name]. The formulation involves [specify dosage, form], with [standardized strength].
Market Size and Demand
The drug operates in the [industry segment], targeting an estimated patient population of approximately [number] in the United States. The market value for this segment is projected at $[value], with compound annual growth rate (CAGR) of [percentage]% over the next five years.
Competitive Landscape
Key competitors include:
- [Competitor 1], with a market share of approximately [percentage]%
- [Competitor 2], with a share of [percentage]%
- Biosimilar or generic options, occupying [percentage]% of the market
The differentiation factors include efficacy profiles, patent exclusivity, and reimbursement policies. Patent expiration is expected in [year], opening the market for generics.
Pricing Dynamics
Current average wholesale acquisition cost (WAC) is $[value] per [unit]. The retail price averages at $[value], with variations based on insurance coverage, geography, and formulary status.
Price projections for the next three to five years consider:
- Patent exclusivity extending until [year]
- Entry of biosimilars or generics impacting prices by up to [percentage]% within two years of patent expiry
- Changes in reimbursement policies potentially reducing net prices by [percentage]%
Pricing Trends
Historically, drug prices in this segment have remained stable or increased modestly, averaging [percentage]% annual growth. Market pressures and patent expirations often lead to a 20-30% price decrease upon generic entry within one year.
Revenue Forecasts
Based on current pricing, sales volume estimates, and market penetration rates, projected revenues for NDC 21922-0049 are:
| Year |
Projected Sales ($M) |
Assumptions |
| 2023 |
[value] |
Stable market share, current price |
| 2024 |
[value] |
Patent expiration, generic entry |
| 2025 |
[value] |
Reduction in net price, increased volume |
Regulatory and Policy Factors
FDA reviews, patent litigations, and legislative changes influence market access. The drug's exclusivity period reduces competition temporarily, impacting pricing.
Key Market Drivers
- Increasing prevalence of target condition
- Advances in formulation delivery systems
- Payer incentives for preferred formulary placement
Risks and Challenges
- Patent expiry leading to generic competition
- Pricing pressure from biosimilars
- Policy changes impacting reimbursement
Summary of Price Projections
| Year |
Price Range (per unit) |
Notes |
| 2023 |
$[value]–$[value] |
Current brand price |
| 2024 |
$[value]–$[value] |
Post-patent expiry, potential generic entry |
| 2025 |
$[value]–$[value] |
Market adjustment as generics penetrate |
Key Takeaways
- The current market for NDC 21922-0049 is characterized by high brand loyalty and patent protection until [year].
- Prices are expected to decline by up to 30% following patent expiration due to generic competition.
- Revenue projections depend heavily on market penetration, reimbursement policies, and the timing of biosimilar entry.
- Demand is driven by an expanding patient base with [condition], supported by clinical research indicating [efficacy data].
- Regulatory factors, patent status, and payer policies remain critical variables influencing future pricing and market share.
FAQs
- When is patent expiry scheduled for NDC 21922-0049?
- How will biosimilar entry affect the price?
- What is the estimated market size for this drug?
- How do reimbursement policies impact pricing?
- What regulatory steps are influencing market access?
Sources
- U.S. Food and Drug Administration (FDA) databases
- IQVIA National Sales Perspectives
- Medicare and Medicaid policy documents
- Market research reports: EvaluatePharma, GlobalData
- Patent filings and expiration timelines [1]
[1]: Specific patent expiration dates and regulatory filings are available through the FDA and patent office databases.
